NCM·Healthcare·$165M·#201 / 520 in Healthcare
PDEX Pro-Dex, Inc.
53SPECULATIVE
CATEGORY BREAKDOWN
GROWTH38
QUALITY55
STABILITY23
VALUATION94
GOVERNANCE100
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+23.7%
38
> 50% strong
Gross Margin
Revenue retained after direct costs
29.3%
39
> 50% strong
Cash Runway
Months of cash at current burn rate
3 months
5
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
45.3%
60
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.2x
94
< 3x strong
Rule of 40
Growth rate plus operating margin
40
80
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
36.8%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-2.0%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PDEX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PDEX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.